Saturday, October 17, 2009

Merck's Gardasil HPV Vaccine Includes Aluminum-Containing Adjuvant (Now Approved For Boys Too!)

Just in case you were curious what was contained in the Gardasil vaccine, you can read Section 11 of the package insert by clicking this sentence. Among many things, the Gardasil vaccine contains an aluminum-containing adjuvant called Amorphous Aluminum Hydroxyphosphate Sulfate. A recent study in the Journal of Inorganic Biochemistry called Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration (2009) (by Christopher Shaw and Michael S. Petrik) examined the possible neurotoxicity of aluminum in vaccines.

Also, Gardasil has been approved by the FDA for boys in this country, so we will likely start seeing boys being crippled from the vaccine's side effects like we have seen in some girls who have received the vaccine.

Merck & Co.’s Gardasil, a vaccine used to prevent cervical cancer in women, won U.S. regulatory approval for preventing genital warts in boys.

The U.S. Food and Drug Administration cleared the vaccine for use in males ages 9 to 26, Merck said today in a statement.

Gardasil protects against a sexually transmitted infection called human papillomavirus, or HPV, that can lead to cervical cancer in women and genital warts and cancer of the penis and anus in men. Gardasil, approved for females ages 9 to 26, is given mostly to school-age girls as a U.S.-recommended routine vaccination.

Source: Bloomberg

Image Source: David Dees

No comments: